Events
Duane Morris Special Counsel Michael Swit to Discuss "Biosimilar Regulations and CMOs"
June 26, 2012 | Webinar
Duane Morris special counsel Michael Swit will be part of a panel discussion on "Biosimilar Regulations and CMOs
" for a FierceBiotech webinar on Tuesday, June 26, 2012, at 11:00 a.m. (Eastern time).
Biosimilar legislation passed in 2010 guaranteed 12 years of patent protection to biotechs from biosimilar competition. But passing the law was the easy part. As the FDA hashes out regulations to implement the law, panelists will help CMOs understand the significance of the legislation to their businesses and how the new legislation may help, or hurt, contract manufacturing for biologics.
For additional information, or to register, please visit the FierceBiotech website.
